Niki BioSolutions, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Niki BioSolutions, Inc. (NIKI) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$28.37 thousand for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-05-11
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 10 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|
| 2025-12-31 | -$28.37K S-4/A · filed 2026-05-11 | ||
| 2024-12-31 | -$422.70K S-4/A · filed 2026-05-11 | ||
| 2023-12-31 | $398.63K S-4/A · filed 2026-05-11 | ||
| 2022-12-31 | $1.92M 6-K · filed 2025-10-08 | ||
| 2020-06-30 | -$29.38K 6-K · filed 2020-09-02 | ||
| 2019-12-31 | $986.24K 20-F · filed 2020-04-29 | ||
| 2019-06-30 | -$1.04M 6-K · filed 2020-09-02 | ||
| 2018-12-31 | $58.55K 20-F · filed 2020-04-29 | ||
| 2017-12-31 | $183.08K 20-F · filed 2020-04-29 |